Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KS › Lawrence › NPI 1508883422
Hospital

Lawrence Memorial Hospital

Lawrence Memorial Hospital was paid $5.31M by Medicaid between Jan 2018 and Nov 2024, across 136 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 28% of everything it billed.

33Billing provider infoLAWRENCE MEMORIAL HOSPITAL
LAWRENCE, KS 66044
33aNPI1508883422assigned 07/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.31M
24GClaims188,431
24DCodes billed136
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kansas

Rank by total paid#6 of 48
Median peer was paid$461K
This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,900$1.55M
201933,138$1.17M
202021,638$595K
202122,255$668K
202228,099$706K
202326,236$386K
2024incomplete15,165$238K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
41899 Unlisted procedure, dentoalveolar structures 28% 752 663 $1.48M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 24,879 19,923 $1.09M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 26,338 23,285 $995K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.3% 7,029 5,906 $335K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 6.1% 3,530 3,376 $326K
80053 Comprehensive metabolic panel 3.6% 20,301 18,589 $189K
87631 2.2% 1,117 1,089 $115K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 24,480 22,136 $106K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 4,190 3,907 $79K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.3% 2,797 1,978 $70K
96375 Therapeutic injection; each additional sequential IV push <1% 1,607 1,471 $51K
96361 Intravenous infusion, hydration; each additional hour <1% 2,760 2,522 $50K
124 more codes
81001 <1% 9,490 $36K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 607 $35K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,611 $27K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 561 $25K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 561 $25K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 449 $24K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 179 $22K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 528 $18K
70450 Computed tomography, head or brain; without contrast material <1% 185 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 384 $13K
87081 <1% 1,523 $13K
71046 Radiologic examination, chest; 2 views <1% 877 $12K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 94 $10K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 348 $9K
84703 <1% 828 $7K
84443 Thyroid stimulating hormone (TSH) <1% 549 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 108 $7K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 219 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 291 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 512 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 338 $5K
83690 <1% 692 $5K
84484 <1% 501 $4K
36415 Collection of venous blood by venipuncture <1% 25,329 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 190 $4K
71045 Radiologic examination, chest; single view <1% 405 $4K
86780 <1% 197 $4K
G0378 Hospital observation service, per hour <1% 58 $3K
87070 <1% 387 $3K
J3490 Unclassified drugs <1% 4,230 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 74 $3K
80061 Lipid panel <1% 237 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 95 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 127 $2K
83874 <1% 231 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 90 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 241 $2K
99070 <1% 564 $2K
87205 <1% 330 $2K
88142 <1% 80 $2K
86803 <1% 96 $2K
83605 <1% 196 $2K
97597 <1% 22 $2K
96376 <1% 106 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 172 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 44 $2K
87186 <1% 123 $1K
85610 <1% 508 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 126 $1K
87430 <1% 113 $1K
71275 Computed tomographic angiography, chest, with contrast material <1% 12 $1K
77067 Screening mammography, bilateral, including computer-aided detection <1% 43 $1K
83735 <1% 237 $1K
93971 <1% 13 $1K
84439 <1% 93 $965.02
87340 <1% 64 $954.34
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 66 $783.10
73630 <1% 40 $744.60
86850 <1% 78 $716.51
82962 <1% 148 $715.96
83655 <1% 48 $707.59
87088 <1% 61 $703.11
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 14 $702.49
84702 <1% 64 $694.08
97161 <1% 18 $660.70
87077 <1% 63 $659.37
82728 <1% 34 $587.40
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 28 $583.11
J7030 Infusion, normal saline solution , 1000 cc <1% 3,588 $565.82
81025 <1% 70 $555.69
73130 <1% 30 $529.19
86901 <1% 82 $521.59
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,254 $469.22
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 48 $441.04
73562 <1% 29 $431.83
86900 <1% 82 $413.47
82607 <1% 28 $400.08
86140 <1% 59 $390.10
86762 <1% 41 $377.99
J2704 Injection, propofol, 10 mg <1% 1,288 $369.69
85379 <1% 48 $347.38
87040 <1% 32 $341.47
82570 <1% 58 $322.09
0001A <1% 52 $318.30
J3010 Injection, fentanyl citrate, 0.1 mg <1% 647 $297.23
0002A <1% 49 $289.72
85652 <1% 58 $282.84
84145 <1% 13 $274.63
73110 <1% 15 $274.61
72100 <1% 16 $265.76
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 32 $258.15
82951 <1% 13 $255.59
85027 <1% 29 $242.45
73610 <1% 15 $231.70
81003 <1% 161 $190.24
J2270 Injection, morphine sulfate, up to 10 mg <1% 83 $186.41
J0780 Injection, prochlorperazine, up to 10 mg <1% 21 $181.23
0011A <1% 20 $173.16
83550 <1% 16 $171.41
0012A <1% 16 $144.58
82950 <1% 19 $143.92
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 180 $142.45
83540 <1% 29 $133.11
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,042 $116.20
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 614 $102.79
84550 <1% 14 $80.20
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 28 $68.29
80164 <1% 15 $62.96
J2060 Injection, lorazepam, 2 mg <1% 54 $59.37
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 44 $43.63
82077 <1% 94 $31.08
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 16 $22.34
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 12 $16.69
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 56 $0.72
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 39 $0.12
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 0% 82 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 27 $0.00
36416 0% 26 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 13 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 206 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 14 $0.00
G9744 Patient not eligible due to active diagnosis of hypertension 0% 43 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 44 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKORTKAMP, SHELLY (PRESIDENT & CEO)